Esculentoside H
Cat. No.：YN350242
| 产品名称: | Esculentoside H |
| CAS No.: | 66656-92-6 |
| Chemical Name: | |
| Synonyms: | |
| 分子量: | 989.10 |
| 分子式: | C₄₈H₇₆O₂₁ |
| SMILES: | O=C([C@]1(CC[C@@](C(OC)=O)(C)C2)[C@]2([H])C3=CC[C@@]4([H])[C@@](C)(CC[C@]5([H])[C@@]4(C[C@H](O)[C@H](O[C@@](OC[C@@H](O[C@]([C@@H]([C@@H](O)[C@@H]6O)O)([H])O[C@@H]6CO)[C@@H]7O)([H])[C@@H]7O)[C@@]5(C)CO)C)[C@]3(C)CC1)O[C@@H]([C@@H]([C@@H](O)[C@@H]8O)O)O[C@@ |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Esculentoside H (EsH) 是从多年生植物Phytolacca esculent的根提取物中分离和纯化的水溶性皂苷。_x000D_ Esculentoside H (EH) 具有抗肿瘤活性，其机制与TNF释放能力有关。_x000D_ Esculentoside H (EsH) 通过阻断 JNK1/2 和NF-κB信号介导的基质金属蛋白酶-9 (MMP-9) 表达抑制结肠癌细胞迁移。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
